DAVID G JOHNSON to E2F1 Transcription Factor
This is a "connection" page, showing publications DAVID G JOHNSON has written about E2F1 Transcription Factor.
Connection Strength
1.923
-
E2F1 and p53 transcription factors as accessory factors for nucleotide excision repair. Int J Mol Sci. 2012 Oct 19; 13(10):13554-68.
Score: 0.401
-
E2F1 promotes the recruitment of DNA repair factors to sites of DNA double-strand breaks. Cell Cycle. 2011 Apr 15; 10(8):1287-94.
Score: 0.361
-
E2F1 suppresses skin carcinogenesis via the ARF-p53 pathway. Oncogene. 2006 Feb 09; 25(6):867-76.
Score: 0.252
-
Repression of androgen receptor transcription through the E2F1/DNMT1 axis. PLoS One. 2011; 6(9):e25187.
Score: 0.093
-
The RB-E2F1 pathway regulates autophagy. Cancer Res. 2010 Oct 15; 70(20):7882-93.
Score: 0.086
-
Transgenic E2F1 expression in the mouse brain induces a human-like bimodal pattern of tumors. Cancer Res. 2007 May 01; 67(9):4005-9.
Score: 0.069
-
Expression of transcription factor E2F1 and telomerase in glioblastomas: mechanistic linkage and prognostic significance. J Natl Cancer Inst. 2005 Nov 02; 97(21):1589-600.
Score: 0.062
-
Inactivation of E2f1 enhances tumorigenesis in a Myc transgenic model. Cancer Res. 2002 Jun 01; 62(11):3276-81.
Score: 0.049
-
ARF differentially modulates apoptosis induced by E2F1 and Myc. Mol Cell Biol. 2002 Mar; 22(5):1360-8.
Score: 0.048
-
Myc lacks E2F1's ability to suppress skin carcinogenesis. Oncogene. 2001 Aug 30; 20(38):5341-9.
Score: 0.046
-
E2F4 and E2F1 have similar proliferative properties but different apoptotic and oncogenic properties in vivo. Mol Cell Biol. 2000 May; 20(10):3417-24.
Score: 0.042
-
The paradox of E2F1: oncogene and tumor suppressor gene. Mol Carcinog. 2000 Mar; 27(3):151-7.
Score: 0.042
-
Regulation of BRCA1 expression by the Rb-E2F pathway. J Biol Chem. 2000 Feb 11; 275(6):4532-6.
Score: 0.042
-
E2F1 has both oncogenic and tumor-suppressive properties in a transgenic model. Mol Cell Biol. 1999 Sep; 19(9):6408-14.
Score: 0.040
-
Increased E2F1 activity induces skin tumors in mice heterozygous and nullizygous for p53. Proc Natl Acad Sci U S A. 1998 Jul 21; 95(15):8858-63.
Score: 0.037
-
Differential activities of E2F family members: unique functions in regulating transcription. Mol Carcinog. 1998 Jul; 22(3):190-8.
Score: 0.037
-
Deregulated expression of E2F1 induces hyperplasia and cooperates with ras in skin tumor development. Oncogene. 1998 Mar 12; 16(10):1267-76.
Score: 0.036
-
High-affinity binding of the cell cycle-regulated transcription factors E2F1 and E2F4 to benzo[a]pyrene diol epoxide-DNA adducts. Mol Carcinog. 1997 Oct; 20(2):216-23.
Score: 0.035
-
Regulation of E2F-1 gene expression by p130 (Rb2) and D-type cyclin kinase activity. Oncogene. 1995 Nov 02; 11(9):1685-92.
Score: 0.031
-
Oncogenic capacity of the E2F1 gene. Proc Natl Acad Sci U S A. 1994 Dec 20; 91(26):12823-7.
Score: 0.029
-
Autoregulatory control of E2F1 expression in response to positive and negative regulators of cell cycle progression. Genes Dev. 1994 Jul 01; 8(13):1514-25.
Score: 0.028
-
Expression of transcription factor E2F1 induces quiescent cells to enter S phase. Nature. 1993 Sep 23; 365(6444):349-52.
Score: 0.027
-
Inactivating E2f1 reverts apoptosis resistance and cancer sensitivity in Trp53-deficient mice. Nat Cell Biol. 2003 Jul; 5(7):655-60.
Score: 0.013
-
E2F-1 gene transfer enhances invasiveness of human head and neck carcinoma cell lines. Cancer Res. 2000 Nov 01; 60(21):5972-6.
Score: 0.011
-
A genetic analysis of the E2F1 gene distinguishes regulation by Rb, p107, and adenovirus E4. Mol Cell Biol. 1993 Oct; 13(10):6314-25.
Score: 0.007